AstraZeneca invests $3.5 billion in R&D and manufacturing in the United States

AstraZeneca has announced $3.5 billion of capital investment in the United States focused on expanding the Company's research and manufacturing footprint by the end of 2026. This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs contributing to the growth of the US economy.

from Breaking World Pharma News https://ift.tt/nwMPUlu